Related Experiment Video
Updated: Jul 21, 2026
08:01
Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal
Published on: May 30, 2012
A nexus between Oct-4 and E1A: implications for gene regulation in embryonic stem cells
H R Schöler1, T Ciesiolka, P Gruss
1Department of Molecular Cell Biology, Max Planck Institute of Biophysical Chemistry, Göttingen, Federal Republic of Germany.
Cell
|July 26, 1991
Summary
Oct-4 and E1A proteins can activate gene transcription independently of distance. Their specific ratio is crucial for efficiency, suggesting E1A acts as a bridging factor for Oct-4 in pluripotent cells.
Area of Science:
- Molecular Biology
- Developmental Biology
- Gene Regulation
Background:
- Oct-4 is a key transcription factor in early mouse embryo pluripotent progenitor cells.
- Distal gene activation in differentiated cells with ectopic Oct-4 requires additional factors.
Purpose of the Study:
- To investigate the sufficiency of Oct-4 and E1A in activating basal transcription machinery.
- To determine the role of the Oct-4 to E1A ratio in transcriptional activation.
- To elucidate the mechanism of Oct-4 mediated transcriptional activation.
Main Methods:
- Co-expression of Oct-4 and E1A in cellular systems.
- Analysis of gene activation independent of distance.
- Biochemical assays to study protein-protein interactions and domain requirements.
Main Results:
- Oct-4 and E1A are sufficient for distance-independent activation of basal transcription.
- The ratio of Oct-4 to E1A is critical; higher levels of either factor reduce efficiency.
- Activation requires a transactivation domain on Oct-4 and conserved domain 3 of E1A, which binds Oct-4.
- E1A acts as a bridging factor between Oct-4 and the basal transcription initiation complex.
Conclusions:
- E1A facilitates Oct-4's interaction with the basal transcription machinery.
- A model is proposed where E1A-like factors bridge Oct-4 in pluripotent cells.
- This finding sheds light on the regulatory mechanisms of pluripotency and gene expression.
Related Concept Videos
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
02:33Combinatorial Gene Control
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
01:14Maintenance of the ES Cell State
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.